Document Detail

ATPase activity and ATP-dependent conformational change in the co-chaperone HOP.
Jump to Full Text
MedLine Citation:
PMID:  24535459     Owner:  NLM     Status:  Publisher    
Co-chaperones help to maintain cellular homeostasis by modulating the activities of molecular chaperones involved in protein quality control. The HSP70/HSP90 organizing protein (HOP) is a co-chaperone that cooperates with HSP70 and HSP90 in catalysis of protein folding and maturation in the cytosol. We show here that HOP has ATP-binding activity comparable to that of HSP70/HSP90, and that HOP slowly hydrolyzes ATP. Analysis of deletion mutants revealed that the ATPase domain of HOP is in the amino-terminal TPR1-DP1-TPR2A segment. In addition, HOP changes its conformation in the presence of ATP. These results indicate that HOP is a unique co-chaperone that undergoes an ATP-dependent conformational change.
Soh Yamamoto; Ganesh Prasad Subedi; Shinya Hanashima; Tadashi Satoh; Michiro Otaka; Hideki Wakui; Ken-Ichi Sawada; Shin-Ichi Yokota; Yoshiki Yamaguchi; Hiroshi Kubota; Hideaki Itoh
Related Documents :
23542009 - Structural basis for the recognition of ubc13 by the shigella flexneri effector ospi.
23932789 - A novel protocol to accelerate dynamic combinatorial chemistry via isolation of ligand-...
24512059 - Identification of 1, 2, 5-oxadiazoles as a new class of senp2 inhibitors using structur...
24900209 - Synthesis and biochemical testing of 3-(carboxyphenylethyl)imidazo[2,1-f][1,2,4]triazin...
22998569 - Recent advances in structure-activity relationship studies on hiv-1 nnrtis.
23369789 - Gsk-3 inhibition: achieving moderate efficacy with high selectivity.
7874449 - Homomeric rho 1 gaba channels: activation properties and domains.
19922539 - Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transp...
11197339 - N-(hydroxyaminocarbonyl)phenylalanine: a novel class of inhibitor for carboxypeptidase a.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-2-17
Journal Detail:
Title:  The Journal of biological chemistry     Volume:  -     ISSN:  1083-351X     ISO Abbreviation:  J. Biol. Chem.     Publication Date:  2014 Feb 
Date Detail:
Created Date:  2014-2-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985121R     Medline TA:  J Biol Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): J Biol Chem
Journal ID (iso-abbrev): J. Biol. Chem
Journal ID (hwp): jbc
Journal ID (pmc): jbc
Journal ID (publisher-id): JBC
ISSN: 0021-9258
ISSN: 1083-351X
Publisher: American Society for Biochemistry and Molecular Biology, 9650 Rockville Pike, Bethesda, MD 20814, U.S.A.
Article Information
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.
Received Day: 24 Month: 1 Year: 2014
Print publication date: Day: 4 Month: 4 Year: 2014
Electronic publication date: Day: 17 Month: 2 Year: 2014
pmc-release publication date: Day: 17 Month: 2 Year: 2014
Volume: 289 Issue: 14
First Page: 9880 Last Page: 9886
PubMed Id: 24535459
ID: 3975032
Publisher Id: M114.553255
DOI: 10.1074/jbc.M114.553255

ATPase Activity and ATP-dependent Conformational Change in the Co-chaperone HSP70/HSP90-organizing Protein (HOP)* Alternate Title:HOP Has ATPase Activity and Alters Its Conformation
Soh Yamamoto§
Ganesh Prasad Subedi
Shinya Hanashima
Tadashi Satoh
Michiro Otaka
Hideki Wakui**
Ken-ichi Sawada**
Shin-ichi Yokota§
Yoshiki Yamaguchi
Hiroshi Kubota
Hideaki Itoh1
From the Department of Life Science, Faculty and Graduate School of Engineering and Resource Science, Akita University, Akita 010-8502, Japan,
the §Department of Microbiology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan,
the Structural Glycobiology Team, Systems Glycobiology Research Group, RIKEN-Max Planck Joint Research Cluster for Systems Chemical Biology, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan,
the Department of Gastroenterology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, Japan, and
the **Third Department of Internal Medicine, Akita University School of Medicine, Akita 010-8543, Japan
1 To whom correspondence should be addressed: Department of Life Science, Faculty of Engineering and Resource Science, 1-1 Tegata Gakuen Town, Akita City 010-8502, Japan. Tel.: 81-18-889-3041; Fax: 81-18-883-3041; E-mail:


The 70 kDa and 90 kDa heat shock proteins (HSP70 and HSP90)2 are major molecular chaperones in the eukaryotic cytosol. These chaperones play essential roles in protein quality control by preventing protein aggregation, catalyzing the folding of newly synthesized proteins, and promoting degradation of denatured proteins (1, , 3). HSP70 recognizes hydrophobic surfaces of unfolded and partially folded proteins, and it releases these substrate proteins after undergoing conformational changes over the course of its ATPase cycle (4). HSP70 consists of a highly conserved N-terminal nucleotide-binding domain (NBD) and a C-terminal substrate-binding domain (SBD) (5, 6). HSP90 consists of three functional domains, the N-terminal, middle, and C-terminal dimerization domains. The middle domain is involved in ATP hydrolysis, client protein binding, and co-chaperone binding, whereas the C-terminal domain is required for HSP90 dimerization (7, 8). During the ATPase cycle, open and closed structures of HSP90 are produced, and these conformations are important for stabilization of the client proteins (9, 10).

HSP70 and HSP90 cooperate with co-chaperones during the process of protein folding, including maturation of steroid hormone receptors, kinases, and p53 (11, 12). The HSP70/HSP90 organizing protein (HOP, also known as stress-inducible protein 1 or STI1) is a co-chaperone that cooperates with HSP70 and HSP90 in protein folding. HOP acts as a scaffold for HSP70/HSP90 and modulates the functions of these chaperones (12, , 16). HOP is a monomeric protein (9, 17) composed of three tetratricopeptide repeat domains (TPR1, TPR2A, and TPR2B) and two aspartic acid-proline domains (DP1 and DP2) (16). The TPR domains are protein-protein interaction modules containing helix-turn-helix structures (18). HOP binds HSP70 and HSP90 through the TPR1 domain or the TPR2B domain and TPR2A domain via ionic interactions (19, , 21). The solution structure of the yeast HOP/STI1 DP domains has been determined by nuclear magnetic resonance (NMR) analysis, which revealed that the DP1 and DP2 domains consist of six and five helices, respectively (21). The DP2 domain provides important support for the chaperone activity of HSP90 (21, 22). However, the detailed mechanisms of HOP-assisted, chaperone-dependent protein folding are largely unknown. Here, we report that HOP has ATPase activity and changes its conformation in the presence of ATP. We discuss the possible roles of ATP-dependent conformational changes in regulating HOP function.

Expression Vectors and Purification

Expression vector encoding human full-length HOP-(1–543) was constructed as previously described (10). DNAs encoding domain-deletion mutants (containing amino acids 106–543, 352–543, 1–359, 1–224, 106–224, 225–309, and 106–309) were generated by polymerase-chain reaction (PCR) using specific primers, and then subcloned into the pCold I hexahistidine-tagged (His6) protein expression vector (Takara, Tokyo, Japan). The resultant vector were transformed into Escherichia coli BL21, and the bacteria were grown in L-broth at 37 °C. Expression of His6-tagged full-length HOP and its deletion mutants were induced in the presence of 1 mM isopropyl-1-thio-β-D-galactopyranoside for 24 h at 15 °C. Bacteria were harvested, resuspended in 10 mM Tris-HCl buffer, pH 7.4, and lysed by sonication on ice. Supernatant was recovered after centrifugation at 20,000 rpm for 5 min at 4 °C and then applied onto a Ni-NTA column (GE Healthcare, Amersham Biosciences) equilibrated with buffer A (300 mM NaCl, 10 mM Tris-HCl, pH 7.4) supplemented with 20 mM imidazole. After the column was washed with ten column volumes of buffer A containing 50 mM imidazole, proteins were eluted with a linear gradient of 100–500 mM imidazole in buffer A. HOP peak fractions were pooled and concentrated by ultrafiltration. Concentrated HOP solution was loaded onto a Superdex 200 HR column (GE Healthcare) equilibrated with buffer B (5% glycerol, 1 mM DTT, 150 mM NaCl in 25 mM HEPES-KOH, pH 7.4). HOP peak fractions were pooled and dialyzed against buffer C (5% glycerol, 1 mM DTT in 25 mM HEPES-KOH, pH 7.4). Purified HOP was frozen using liquid nitrogen and stored at −80 °C. Purification of HSP70 and HSP90 from porcine brain was performed as described previously (23, 24). Protein concentration was determined by the bicinchoninic acid method using the BCA Protein Assay kit (Pierce) and bovine serum albumin as the standard.

Measurement of ATPase Activity and Kinetic Analysis

HOP (20 μM), porcine HSP70 (2 μM), and porcine HSP90 (4 μM) were incubated with ATP in buffer D (1 mM DTT, 5 mM MgCl2, 50 mM KCl in 25 mM HEPES-KOH, pH 7.4) at 37 °C for 90 min. All proteins were treated as monomers for purposes of calculating concentration. The amount of hydrolyzed ATP was determined as previously described (24). Kinetic parameters were calculated by non-linear regression using the Michaelis-Menten equation and the Origin 6.1 software (Originlab, Northampton, MA). To determine ATPase activity, domain-deletion mutants (20 μM) were incubated with ATP in buffer D at 37 °C for 120 min.

Protease Sensitivity Test

HOP (4 μM) was suspended in buffer E (5 mM MgCl2, 100 mM KCl in 25 mM HEPES-KOH, pH 7.4) and digested with 10 nM TPCK-trypsin and 30 nM proteinase K for 30 min at 37 °C in the presence of 5 mM nucleotides. After incubation, partially digested HOP fragments were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by Coomassie Brilliant Blue staining. Band intensities were analyzed by the public-domain ImageJ software (US Natl. Inst. Health).

Determination of the N-terminal Amino Acid Sequence

The protease-treated samples were separated by SDS-PAGE on 11% gels and blotted onto polyvinylidene difluoride filters. After blotting, the filter was stained with 0.025% Coomassie Brilliant Blue R250 in 40% ethanol for 30 min at room temperature, de-stained by washing in 50% ethanol, and washed in 100% ethanol. Protein bands excised from filters were N-terminally sequenced using a LC 491 protein sequencer (Applied Biosystems).

NMR Spectrometry

NMR experiments were recorded using a 600 MHz spectrometer (DRX-600, Bruker Biospin) equipped with a 5 mm triple-resonance inverse (TXI) probe or with a 5 mm BBO (Broadband Observe) probe. For monitoring of protein signals, proteins (0.3 mM) were dissolved in 20 mM potassium phosphate buffer (pH 6.5), 50 mM KCl, and 5 mM MgCl2 containing 10% (v/v) D2O, and then titrated ATP at a 10-fold molar excess. Probe temperature was set at 25 or 5 °C, and the water signal was suppressed using the WATERGATE pulse sequence.

For determination of dissociation constants, all the samples were prepared in 25 mM MES and 5 mM MgCl2, pH 6.5. For the titration experiment, HOP was used at a concentration 135 μM. Various amounts of ATP stock solutions were added to HOP solutions, and 1H and 31P NMR spectra of ATP were recorded after each titration. To determine the dissociation constant (Kd) of HOP with ATP, the chemical shift changes of H2 (8.25 ppm) and H8 (7.88 ppm) protons of ATP were taken, because these proton signals exhibited chemical shift changes as the ATP concentration was gradually increased. NMR data were processed using XWIN-NMR ver. 3.5 (Bruker Biospin).

Kd values were determined by a non-linear fitting method using Equation 1.

[Formula ID: FD1]
Here, Lo and Po indicate the molar concentrations of HOP and ATP, respectively; Dobs is the observed chemical shift change; and Dmax is the change in chemical shift at saturation.

HOP Binds ATP with an Affinity Comparable to That of HSP70 or HSP90 and Slowly Hydrolyzes ATP

Using purified HOP expressed in Escherichia coli, we analyzed the ATPase activity of the purified HOP and determined the kinetic parameters using the Michaelis-Menten equation (Fig. 1A). The catalytic constant (kcat), which represents the number of ATP molecules hydrolyzed by HOP, was estimated to be 3.8 ± 0.3 × 10−3 mol ATP/mol HOP/min. The ATP hydrolysis rate of HOP was lower than those of porcine brain HSP70 (kcat = 85.3 ± 15.0 × 10−3) and HSP90 (kcat = 27.9 ± 3.4 × 10−3). To determine the dissociation constant (Kd) of HOP for ATP, we performed NMR titration experiments. We first examined the 31P chemical shift changes of the ATP phosphate group; no significant changes were observed (data not shown). Therefore, we analyzed the chemical shift changes on adenine H2 and H8 protons of ATP. We observed chemical shift changes in both the H2 and H8 proton signals at each titration point (Fig. 1C). These chemical shift changes were used for the determination of Kd values using non-linear fitting methods, and Kd was estimated to be 350 μM (Fig. 1D). These results indicated that HOP binds to ATP with considerable affinity and then slowly hydrolyzes ATP.

To determine the domains responsible for the ATPase activity, we constructed a series of deletion mutants and purified the protein segments from bacteria (Fig. 2A). These segments were incubated with ATP at 37 °C for up to 120 min, and then ATP hydrolysis activities were determined (Fig. 2, B and C). The ATPase activity of the HOP-(1–359) fragment (TPR1-TPR2A) was very similar to that of full-length HOP-(1–543), defined here as 100%. By contrast, the 106–543 (ΔTPR1) and 352–543 (TPR2B-DP2) fragments exhibited significantly reduced ATPase activities (57.2 ± 4.3% and 6.1 ± 8.5%, respectively). These results indicated that the 1–359 region plays an important role in ATPase activity. We further analyzed the 1–359 region by analyzing smaller sub-fragments. The ATPase activity of the 106–359 fragment (DP1-TPR2A) was 36.0 ± 3.1%, and the ATPase activities of the 1–224 (TPR1-DP1), 106–224 (DP1 domain), and 225–359 (TPR2A domain) fragments were almost negligible (9.6 ± 2.7%, 5.7 ± 2.5%, and 1.4 ± 1.8%, respectively). These results indicated that the 106–359 region is essential for the ATPase activity of HOP, where the 1–105 region makes a significant, but smaller contribution to ATPase activity.

We next used NMR spectroscopy to determine whether ATP directly interacts with the ATPase domain of HOP (Fig. 3). Specifically, we obtained the 1H NMR spectra of full-length HOP and the 1–359 region containing the ATPase domain (TPR1-TPR2A). 1H chemical shift changes were observed for full-length HOP and the ATPase domain in the presence of ATP. These data indicated that ATP directly binds the ATPase domain of HOP.

To identify the ATP-binding site of human HOP, we searched the amino acid sequence of HOP for known ATP-binding motifs, i.e. the Walker A motif (G/AXXXXGK(X)S/T, where X indicates any amino acid), also know as the P-loop and phosphate-binding motif (25) and the Walker B motif (R/K-X2–10-O-X-O-D/E, where O indicates a hydrophobic amino acid) (26). The Walker B motif binds a divalent ion and the adenosine residue of ATP, and this motif is present in HSP70, HSP90, and other chaperones (27). HOP contains a Walker B motif in the TPR1, DP1, and TPR2B domains (Fig. 4A), but no Walker A motif. We focused on the Walker B motif of the DP1 domain because this region was essential for ATP hydrolysis (Fig. 3, B and C). To disrupt the Walker B motif, we constructed the D186A mutant in DP1. However, this mutation caused no significant change in ATPase activity (Fig. 4B). These results indicate that the Asp-186 residue is not essential for HOP ATPase activity, and suggest that HOP binds ATP using motifs other than Walker A and B. The NBD of the HSP70 and HSP90 structures are similar to those of actin and DNA-gyrase B, respectively (5, 28), and the ATP hydrolysis mechanisms of these non-Walker ATPases were recently elucidated (4, 8, 12, 21). Another non-Walker ATPase is the chaperonin GroEL; this chaperone has a unique ATP-binding motif (DGTTT) and phosphate-recognition region, i.e. a P-loop arrangement located between two α-helices (25, 29). Thus, HOP may contain non-Walker ATP-binding motifs, although these motifs remain to be determined.

HOP Changes Its Conformation in the Presence of ATP

The 1H chemical shift change of full-length HOP and the 1–359 region containing the ATPase domain suggested that HOP might undergo conformational changes upon ATP binding (Fig. 3). In addition, most molecular chaperones change their conformations during ATP binding and hydrolysis (8). To determine whether HOP exhibits ATP-dependent conformational changes, we first performed protease digestion assays (30). HOP was incubated with trypsin in the presence and absence of various nucleotides (Fig. 5). HOP was more effectively protected from trypsin digestion in the presence of ATP (Fig. 5A, lane 3) than in the presence of ADP and AMP-PNP, a non-hydrolyzable analog of ATP; the protection efficiency was 54.3 ± 7.5% for ATP, 31.0 ± 8.9% for ADP, and 28.6 ± 10.1% for AMP-PNP, respectively (Fig. 5B). Furthermore, the proteinase K digestion experiment suggests that the conformation of HOP in the presence of ATP differs from that in the presence of ADP or AMP-PNP, because the proteinase K-digested HOP fragments produced in the presence of ATP were partly different from those produced in the presence of ADP or AMP-PNP (Fig. 5C). Although HSP70 and HSP90 change their conformations upon nucleotide binding and hydrolysis (8, 31), the chaperonin CCT/TRiC changes its conformation only during ATP hydrolysis but not upon nucleotide binding (30). These observations suggest that the role of HOP in the ATP-dependent conformational changes may be similar to that of CCT/TRiC, but not to those of HSP70 and HSP90.

We next investigated the effect of ATP on the secondary structures of HOP by analysis of circular dichroism (CD) spectra. However, no significant change was detected (data not shown). Taken together with the results of the NMR and protease digestion experiments (Figs. 3A and 5), these results suggest that in the presence of ATP, HOP changes the relative orientations, but not the secondary structures, of its domain.

To further analyze the regions affected by the ATP-dependent conformational changes, we determined the amino acid sequences of trypsin-digested HOP fragments (Fig. 6, A and B). This sequencing analysis revealed that the region between TPR1 and DP1 was sensitive to protease digestion. Similarly, the hinge region between DP1 and TPR2A was susceptible to enzymatic cleavage. Because, the relative proportions of the fragments produced by digestion at these cleavage sites (#3, #4, and #5) changed in the presence of ATP, these finding indicated that the structure of HOP is altered, at least somewhat, at the N-terminal region near the DP1 domain. However, the level of the large #2 fragment rose in the presence of ATP, suggesting that the conformation of the C-terminal region is also affected by ATP. Thus, the conformational change at the N-terminal ATPase domain may trigger structural alteration of the C-terminal domain, although this possibility remains to be conclusively demonstrated. Nevertheless, these observations support the notion that the ATP-dependent conformational change of HOP occurs throughout the entire HOP molecule, rather than in a small restricted region.

HOP is a multi-domain protein containing three TPR and two DP domains. The TPR domains are protein-interaction modules that act as a scaffold for the HSP complex. TPR1 and TPR2B bind to HSP70, whereas TPR2A binds to HSP90 (19, 21). Recently, the TPR1-DP1 segment was suggested to serve as an HSP70-client delivery system for the TPR2A-TPR2B-DP2 segment, because HSP70 changes the HOP binding domain from TPR1 to TPR2B during the maturation of substrate proteins (21). The role of the DP1 domain is not well understood (32, 33). By contrast, the DP2 domain is known to be essential for HSP90-assisted protein maturation, because mutants lacking the DP2 domain are unable to assist in glucocorticoid receptor activation (21, 22, 34). In this study, we demonstrated that HOP changes its conformation in the presence of ATP. We also revealed that the central ATPase domain is localized at the DP1-TPR2A segment, and that the TPR1 domain plays an additional role in the ATPase activity. Taken together with the fact that HOP changes its conformation upon HSP90 binding, these observations suggest that the ATP-dependent conformational change of HOP may contribute to HSP70/HSP90-assisted protein folding and maturation by rearranging the orientations of the five domains of HOP (35).

HOP, which is ubiquitously expressed in all cell type, and localizes in the cytoplasm, nucleus, and endoplasmic reticulum, as well as on the cell surface (33, 36, , 41). Transportation of HOP from the cytoplasm to the nucleus is regulated by phosphorylation (41). HOP affects maturation of the cystic fibrosis transmembrane conductance regulator protein through S-nitrosylation (37). In addition, HOP functions in neuroprotection and neuritogenesis by interacting with the prion protein on the cell surface (40, 42). These studies suggest that HOP has a variety of functions in vivo, in addition to its co-chaperone function for HSP70 and HSP90.

Based on our finding, we conclude that, cooperation between the N-terminal ATPase domain and the C-terminal chaperone interacting domain may be required for co-chaperone activity of HOP or other HOP-dependent cellular functions.


*This work was supported by a Grant-in-Aid for Young Scientists (B), a Sasakawa Scientific Research Grant from the Japan Science Society (to S. Y.), and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. K. and H. I.).

2The abbreviations used are:

HSP heat shock protein
HOP HSP70/HSP90-organizing protein
NBD nucleotide-binding domain
SBD substrate-binding domain
AMP-PNP adenosine 5′-(β,γ-imino)triphosphate.


We thank members of the Systems Glycobiology Research Group, RIKEN, for their suggestions and valuable discussion.

1.. Hartl F. U.,Bracher A.,Hayer-Hartl M.. (Year: 2011) Molecular chaperones in protein folding and proteostasis. Nature475, 324–33221776078
2.. Itoh H.,Tashima Y.. (Year: 1991) The stress (heat shock) proteins. Int. J. Biochem. 23, 1185–11911794443
3.. Kubota H.. (Year: 2009) Quality control against misfolded proteins in the cytosol: a network for cell survival. J. Biochem. 146, 609–61619737776
4.. Mayer M. P.,Bukau B.. (Year: 2005) Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol. Life Sci. 62, 670–68415770419
5.. Flaherty K. M.,DeLuca-Flaherty C.,McKay D. B.. (Year: 1990) Three-dimensional structure of the ATPase fragment of a 70K heat-shock cognate protein. Nature346, 623–6282143562
6.. Morshauser R. C.,Hu W.,Wang H.,Pang Y.,Flynn G. C.,Zuiderweg E. R.. (Year: 1999) High-resolution solution structure of the 18 kDa substrate-binding domain of the mammalian chaperone protein Hsc70. J. Mol. Biol. 289, 1387–140310373374
7.. Ali M. M.,Roe S. M.,Vaughan C. K.,Meyer P.,Panaretou B.,Piper P. W.,Prodromou C.,Pearl L. H.. (Year: 2006) Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex. Nature440, 1013–101716625188
8.. Mayer M. P.. (Year: 2010) Gymnastics of molecular chaperones. Mol. Cell39, 321–33120705236
9.. Li J.,Richter K.,Buchner J.. (Year: 2011) Mixed Hsp90-cochaperone complexes are important for the progression of the reaction cycle. Nat. Struct. Mol. Biol. 18, 61–6621170051
10.. Kubota H.,Yamamoto S.,Itoh E.,Abe Y.,Nakamura A.,Izumi Y.,Okada H.,Iida M.,Nanjo H.,Itoh H.,Yamamoto Y.. (Year: 2010) Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma. Cell Stress Chaperones15, 1003–101120617406
11.. Smith D. F.,Toft D. O.. (Year: 2008) Minireview: the intersection of steroid receptors with molecular chaperones: observations and questions. Mol. Endocrinol. 22, 2229–224018451092
12.. Wegele H.,Müller L.,Buchner J.. (Year: 2004) Hsp70 and Hsp90–a relay team for protein folding. Rev. Physiol. Biochem. Pharmacol. 151, 1–4414740253
13.. Richter K.,Muschler P.,Hainzl O.,Reinstein J.,Buchner J.. (Year: 2003) Sti1 is a non-competitive inhibitor of the Hsp90 ATPase. Binding prevents the N-terminal dimerization reaction during the ATPase cycle. J. Biol. Chem. 278, 10328–1033312525481
14.. Wegele H.,Haslbeck M.,Reinstein J.,Buchner J.. (Year: 2003) Sti1 is a novel activator of the Ssa proteins. J. Biol. Chem. 278, 25970–2597612716905
15.. Wegele H.,Wandinger S. K.,Schmid A. B.,Reinstein J.,Buchner J.. (Year: 2006) Substrate transfer from the chaperone Hsp70 to Hsp90. J. Mol. Biol. 356, 802–81116403523
16.. Odunuga O. O.,Longshaw V. M.,Blatch G. L.. (Year: 2004) Hop: more than an Hsp70/Hsp90 adaptor protein. Bioessays26, 1058–106815382137
17.. Yi F.,Doudevski I.,Regan L.. (Year: 2010) HOP is a monomer: investigation of the oligomeric state of the co-chaperone HOP. Protein Sci. 19, 19–2519866486
18.. Blatch G. L.,Lässle M.. (Year: 1999) The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. Bioessays21, 932–93910517866
19.. Scheufler C.,Brinker A.,Bourenkov G.,Pegoraro S.,Moroder L.,Bartunik H.,Hartl F. U.,Moarefi I.. (Year: 2000) Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine. Cell101, 199–21010786835
20.. Kajander T.,Sachs J. N.,Goldman A.,Regan L.. (Year: 2009) Electrostatic interactions of Hsp-organizing protein tetratricopeptide domains with Hsp70 and Hsp90: computational analysis and protein engineering. J. Biol. Chem. 284, 25364–2537419586912
21.. Schmid A. B.,Lagleder S.,Grawert M. A.,Rohl A.,Hagn F.,Wandinger S. K.,Cox M. B.,Demmer O.,Richter K.,Groll M.,Kessler H.,Buchner J.. (Year: 2012) The architecture of functional modules in the Hsp90 co-chaperone Sti1/Hop. EMBO J.
22.. Flom G.,Weekes J.,Williams J. J.,Johnson J. L.. (Year: 2006) Effect of mutation of the tetratricopeptide repeat and asparatate-proline 2 domains of Sti1 on Hsp90 signaling and interaction in Saccharomyces cerevisiae. Genetics172, 41–5116219779
23.. Ishida R.,Takaoka Y.,Yamamoto S.,Miyazaki T.,Otaka M.,Watanabe S.,Komatsuda A.,Wakui H.,Sawada K.,Kubota H.,Itoh H.. (Year: 2008) Cisplatin differently affects amino terminal and carboxyl terminal domains of HSP90. FEBS Lett. 582, 3879–388318955054
24.. Yamamoto S.,Nakano S.,Owari K.,Fuziwara K.,Ogawa N.,Otaka M.,Tamaki K.,Watanabe S.,Komatsuda A.,Wakui H.,Sawada K.,Kubota H.,Itoh H.. (Year: 2010) Gentamicin inhibits HSP70-assisted protein folding by interfering with substrate recognition. FEBS Lett. 584, 645–65120026329
25.. Vetter I. R.,Wittinghofer A.. (Year: 1999) Nucleoside triphosphate-binding proteins: different scaffolds to achieve phosphoryl transfer. Q. Rev. Biophys. 32, 1–5610800520
26.. Traut T. W.. (Year: 1994) The functions and consensus motifs of nine types of peptide segments that form different types of nucleotide-binding sites. Eur. J. Biochem. 222, 9–198200357
27.. Ghosh J. G.,Houck S. A.,Doneanu C. E.,Clark J. I.. (Year: 2006) The β4-β8 groove is an ATP-interactive site in the α crystallin core domain of the small heat shock protein, human αB crystallin. J. Mol. Biol. 364, 364–37517022999
28.. Prodromou C.,Roe S. M.,O'Brien R.,Ladbury J. E.,Piper P. W.,Pearl L. H.. (Year: 1997) Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell90, 65–759230303
29.. Boisvert D. C.,Wang J.,Otwinowski Z.,Horwich A. L.,Sigler P. B.. (Year: 1996) The 2.4 A crystal structure of the bacterial chaperonin GroEL complexed with ATPγS. Nat. Struct. Biol. 3, 170–1778564544
30.. Meyer A. S.,Gillespie J. R.,Walther D.,Millet I. S.,Doniach S.,Frydman J.. (Year: 2003) Closing the folding chamber of the eukaryotic chaperonin requires the transition state of ATP hydrolysis. Cell113, 369–38112732144
31.. Hessling M.,Richter K.,Buchner J.. (Year: 2009) Dissection of the ATP-induced conformational cycle of the molecular chaperone Hsp90. Nat. Struct. Mol. Biol. 16, 287–29319234467
32.. Flom G.,Behal R. H.,Rosen L.,Cole D. G.,Johnson J. L.. (Year: 2007) Definition of the minimal fragments of Sti1 required for dimerization, interaction with Hsp70 and Hsp90 and in vivo functions. Biochem. J. 404, 159–16717300223
33.. Gaiser A. M.,Brandt F.,Richter K.. (Year: 2009) The non-canonical Hop protein from Caenorhabditis elegans exerts essential functions and forms binary complexes with either Hsc70 or Hsp90. J. Mol. Biol. 391, 621–63419559711
34.. Carrigan P. E.,Riggs D. L.,Chinkers M.,Smith D. F.. (Year: 2005) Functional comparison of human and Drosophila Hop reveals novel role in steroid receptor maturation. J. Biol. Chem. 280, 8906–891115632128
35.. Onuoha S. C.,Coulstock E. T.,Grossmann J. G.,Jackson S. E.. (Year: 2008) Structural studies on the co-chaperone Hop and its complexes with Hsp90. J. Mol. Biol. 379, 732–74418485364
36.. Song H. O.,Lee W.,An K.,Lee H. S.,Cho J. H.,Park Z. Y.,Ahnn J.. (Year: 2009) C. elegans STI-1, the homolog of Sti1/Hop, is involved in aging and stress response. J. Mol. Biol. 390, 604–61719467242
37.. Marozkina N. V.,Yemen S.,Borowitz M.,Liu L.,Plapp M.,Sun F.,Islam R.,Erdmann-Gilmore P.,Townsend R. R.,Lichti C. F.,Mantri S.,Clapp P. W.,Randell S. H.,Gaston B.,Zaman K.. (Year: 2010) Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy. Proc. Natl. Acad. Sci. U.S.A. 107, 11393–1139820534503
38.. Gangaraju V. K.,Yin H.,Weiner M. M.,Wang J.,Huang X. A.,Lin H.. (Year: 2011) Drosophila Piwi functions in Hsp90-mediated suppression of phenotypic variation. Nat. Genet. 43, 153–15821186352
39.. Chen L.,Hamada S.,Fujiwara M.,Zhu T.,Thao N. P.,Wong H. L.,Krishna P.,Ueda T.,Kaku H.,Shibuya N.,Kawasaki T.,Shimamoto K.. (Year: 2010) The Hop/Sti1-Hsp90 chaperone complex facilitates the maturation and transport of a PAMP receptor in rice innate immunity. Cell Host Microbe7, 185–19620227662
40.. Zanata S. M.,Lopes M. H.,Mercadante A. F.,Hajj G. N.,Chiarini L. B.,Nomizo R.,Freitas A. R.,Cabral A. L.,Lee K. S.,Juliano M. A.,de Oliveira E.,Jachieri S. G.,Burlingame A.,Huang L.,Linden R.,Brentani R. R.,Martins V. R.. (Year: 2002) Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21, 3307–331612093732
41.. Longshaw V. M.,Chapple J. P.,Balda M. S.,Cheetham M. E.,Blatch G. L.. (Year: 2004) Nuclear translocation of the Hsp70/Hsp90 organizing protein mSTI1 is regulated by cell cycle kinases. J. Cell Sci. 117, 701–71014754904
42.. Lopes M. H.,Hajj G. N.,Muras A. G.,Mancini G. L.,Castro R. M.,Ribeiro K. C.,Brentani R. R.,Linden R.,Martins V. R.. (Year: 2005) Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J. Neurosci. 25, 11330–1133916339028


[Figure ID: F1]

HOP has ATPase activity.A, plot of the HOP ATP hydrolysis rate versus ATP concentration. The kinetic parameter was calculated by non-linear regression using the Michaelis-Menten equation. Means and standard deviations (S.D.) from at least three independent measurements are shown. B, structure of ATP. Arrows indicate the determined positions of the H2 and H8 protons of ATP. C, 1H-NMR spectra of ATP titration with HOP at 5 °C. D, plot of the change in chemical signal of protons (in ppm) versus molar ratio of ATP and HOP. Average of the H2 and H8 proton chemical shifts is shown. The broken line indicates theoretical curves obtained using the equation described under “Experimental Procedures.”

[Figure ID: F2]

The 1–359 region of HOP is the central domain responsible for ATPase activity.A, purified deletion mutants of human HOP (1.5 μg/lane) were separated by SDS-PAGE. B, HOP mutants (20 μM each) were incubated with 0.5 mM ATP for 120 min, and hydrolyzed ATP (μM) was determined. C, relative ATPase activities of HOP deletion mutants. HOP deletion mutants were incubated with 0.5 mM ATP. The ATPase activity of HOP-(1–543) (full-length) is defined as 100%. Means and S.D. from at least three independent experiments are shown. *, p < 0.01; **, p < 0.001.

[Figure ID: F3]

1H-NMR spectra (amide region) of HOP-(1–543) and HOP-(1–359) titrated with ATP.1H-NMR spectra of 0.3 mM full-length HOP-(1–543) (A) and 0.3 mM HOP-(1–359) (B) measured at 25 °C in the absence (black) or presence of 10-fold molar excess of ATP (red). Signals marked with asterisk are derived from ATP.

[Figure ID: F4]

ATPase activity of HOP is unaffected by the D186A mutation.A, arrows indicate the starting points of domains, and gray boxes represents Walker B motif. Asterisk shows the mutated aspartic acid residue at position 186. B, plot of ATP hydrolysis rate versus ATP concentration. Activities of wild-type HOP and the D186A mutant are indicated by black and broken lines, respectively. Means and S.D. from at least three independent measurements are shown.

[Figure ID: F5]

HOP changes its conformation in the presence of nucleotides.A, HOP (3 μM) was incubated for 30 min at 37 °C with or without TPCK-trypsin (10 nM) in the presence of nucleotides (5 mM), and then separated by SDS-PAGE. B, band intensity of undigested HOP was quantified from three independent measurements. *, p < 0.05. C, HOP (3 μM) was incubated for 30 min at 37 °C with or without proteinase K (30 nM) in the presence of nucleotides (5 mM), and then separated by SDS-PAGE.

[Figure ID: F6]

The ATP-dependent conformational change of HOP occurs throughout the entire HOP molecule.A, time course of TPCK-trypsin digestion of HOP. After incubation with or without ATP, samples were analyzed by SDS-PAGE. B, N-terminal amino acid sequences obtained using a protein sequencer are shown; numbers indicate the corresponding bands (see panel A).

Article Categories:
  • Protein Structure and Folding

Keywords: Heat Shock Protein, Hsp90, Molecular Chaperone, Protein Complexes, Protein Structure.

Previous Document:  Long-term parental methamphetamine exposure of mice influences behavior and hippocampal DNA methylat...
Next Document:  Prognostic factors for renal allograft survival in patients with immunoglobulin A nephropathy: A cas...